Company attributes
Venture Capital Firm attributes
Other attributes
Qi Ming Venture Partners is a venture capital firm in Shanghai that focuses on investing in consumer, healthcare, information technology and clean technology sectors. Founded 2006 in Shanghai, China, it invests in early stage ventures, late stage ventures, post-IPO, private equity, series B, series A, series C, and series D rounds. Its portfolio companies include Abbisko Therapeutics, Bouffalo Lab Clinflash, Heathcare Technology, Nice Tuan, Sunny Dental, Yuanxin Huibao, KeChow Pharma, Clinflash Heathcare Technology, OriginCell and Chaodian Culture. As of April 2020, Qiming Venture Partners has made 559 investments. Their most recent investment was on March 25, 2020, when Abbisko Therapeutics raised $70M. Qiming Venture Partners has had 38 exits, the most notable of which include Xiaomi, Bilibili, and Musical.ly. The company has raised 15 funds, their latest being Qiming Venture Partners VII.
